Short communicationTigecycline has no effect on cytokine release in an ex vivo endotoxin model of human whole blood
Introduction
Tigecycline, the first member of the antibiotic class of glycylglycines, exhibits a long plasma elimination half-life of ca. 50–70 h and exerts broad antimicrobial activity, including meticillin-resistant Staphylococcus aureus and extended-spectrum β-lactamase-producing bacilli [1]. These characteristics render tigecycline an attractive therapeutic option in the therapy of bacteraemia emanating from complicated infections of soft tissue, the intra-abdominal compartment or the urinary tract.
It is well known from numerous in vitro and animal models that certain classes of antibiotics, i.e. fluoroquinolones, oxazolidinones (linezolid), clindamycin, fosfomycin and tetracyclines, are able to modulate the cytokine response in experimental endotoxaemia [2], [3], [4], [5], [6], [7], [8]. Among others, antibiotics of the tetracycline family were found to protect mice against lethal doses of lipopolysaccharide (LPS). In addition, the tetracyclines are considered to reduce significantly the liberation of tumour necrosis factor-alpha (TNFα) and interleukin (IL)-1β by LPS-stimulated murine and human monocytes in a concentration-dependent manner [6], [7], [8].
Hence, the aim of the present study was to investigate the potential ability of the structurally closely related compound tigecycline to influence the release of the most relevant proinflammatory cytokines IL-1β, IL-6 and TNFα. These cytokines are critically involved in the early phase of systemic inflammation [9]. An established model of endotoxaemia in whole blood was used in an ex vivo setting [5], [6], [7], [8], [9], [10].
Section snippets
General and study subjects
The study took place at associated medical centers and research laboratories of J&P Medical Research Ltd., Vienna, Austria. Ten healthy subjects underwent routine health screening examination including extensive blood laboratory testing. After informed consent was obtained, fresh whole blood (which otherwise would have been discarded) from these anonymised subjects was used for the present in vitro experiment. Whole blood from seven subjects was incubated with a tigecycline concentration of 1
ELISA measurements of IL-1β, IL-6 and TNFα
The concentration versus time profiles of IL-1β, IL-6 and TNFα in the supernatant after incubation of whole blood over a period of 2 h and 4 h with saline, tigecycline, LPS, or LPS plus tigecycline (1 μg/mL and 100 μg/mL) are depicted in Fig. 1 and Table 1.
As shown, the concentrations of all tested cytokines increased significantly after 4 h of incubation with 50 pg/mL LPS compared with baseline. No significant difference in proinflammatory cytokine concentrations was shown between incubation with
Discussion
A large number of in vitro and in vivo models of LPS-induced systemic inflammation have convincingly shown that the class of tetracyclines is able to exert immunomodulatory effects [6], [7], [8]. Because of the structurally close relationship of tigecycline to the tetracyclines, we hypothesised that an immunomodulatory action might also be expected for this new compound.
This speculation is triggered by the fact that tigecycline accumulates in body cells and is rapidly taken up by peripheral
References (15)
- et al.
Linezolid diminishes inflammatory cytokine production from human peripheral blood mononuclear cells
Arch Med Res
(2006) - et al.
Is experimental endotoxemia in humans suitable for simulating antibiotic pharmacokinetics in sepsis and septic shock? A pilot study using the model compound fosfomycin
Int J Antimicrob Agents
(2008) - et al.
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing Enterobacteriaceae: report from SENTRY Antimicrobial Surveillance Program
Antimicrob Agents Chemother
(2008) - et al.
Protection against lipopolysaccharide-induced death by fluoroquinolones
Antimicrob Agents Chemother
(2000) - et al.
Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages
Antimicrob Agents Chemother
(2003) - et al.
Immunomodulatory effects of fosfomycin in an endotoxin model in human blood
J Antimicrob Chemother
(2007) - et al.
Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion
Infect Immun
(1996)
Cited by (5)
Influence of Antibacterial Drugs on Immune and Inflammatory Systems
2019, Nijkamp and Parnham’s Principles of Immunopharmacology: Fourth revised and extended editionImmunomodulatory Effects of Tigecycline in Balb/C Mice
2018, Acta PharmaceuticaEffect of tigecycline on the production of selected cytokines and counts of murine CD4 <sup>+</sup> and CD8 <sup>+</sup> T cells - an in vitro study
2018, Polish Journal of Veterinary SciencesTigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokines
2009, Immunopharmacology and Immunotoxicology